Growth Metrics

Incyte (INCY) EPS (Weighted Average and Diluted) (2016 - 2025)

Incyte (INCY) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $1.46 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 62.22% year-over-year to $1.46, compared with a TTM value of $6.41 through Dec 2025, up 4173.33%, and an annual FY2025 reading of $6.41, up 4173.33% over the prior year.
  • EPS (Weighted Average and Diluted) was $1.46 for Q4 2025 at Incyte, down from $2.11 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $2.54 in Q4 2021 and bottomed at -$2.04 in Q2 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.75, with a median of $0.76 recorded in 2023.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 1271.43% in 2021, then crashed 326.67% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at $2.54 in 2021, then tumbled by 95.28% to $0.12 in 2022, then skyrocketed by 641.67% to $0.89 in 2023, then rose by 1.12% to $0.9 in 2024, then surged by 62.22% to $1.46 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for INCY at $1.46 in Q4 2025, $2.11 in Q3 2025, and $2.04 in Q2 2025.